Crossmark

Targeting MKK3 as a novel anticancer strategy: molecular mechanisms and therapeutical implications

Published Online: 2015-01-29

Authors

Baldari, S

Ubertini, V

Garufi, A

D'Orazi, G

Bossi, G
License Information

Text and Data Mining valid from 2015-01-29

Version of Record valid from 2015-01-29
More Information

Article History

Received: 22 October 2014

Revised: 11 December 2014

Accepted: 15 December 2014

First Online: 29 January 2015

Competing interests

: The authors declare no conflict of interest.

Document is current